| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
CTLA-4 gene variant -1661A>G may predict the onset of endocrine adverse events in metastatic melanoma patients treated with ipilimumab
|
Queirolo, Paola
|
|
2018
|
97 |
C |
p. 59-61
|
artikel
|
| 2 |
Efficacy and safety of single-agent pan-human epidermal growth factor receptor (HER) inhibitor dacomitinib in locally advanced unresectable or metastatic skin squamous cell cancer
|
Cavalieri, S.
|
|
2018
|
97 |
C |
p. 7-15
|
artikel
|
| 3 |
Efficacy of cabazitaxel rechallenge in heavily treated patients with metastatic castration-resistant prostate cancer
|
Thibault, Constance
|
|
2018
|
97 |
C |
p. 41-48
|
artikel
|
| 4 |
Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer
|
Aparicio, T.
|
|
2018
|
97 |
C |
p. 16-24
|
artikel
|
| 5 |
Immunotherapy-induced Addison's disease: A rare, persistent and potentially lethal side-effect
|
Hescot, S.
|
|
2018
|
97 |
C |
p. 57-58
|
artikel
|
| 6 |
Impact of neoadjuvant chemotherapy and pathological complete response on eligibility for breast-conserving surgery in patients with early breast cancer: A meta-analysis
|
Criscitiello, Carmen
|
|
2018
|
97 |
C |
p. 1-6
|
artikel
|
| 7 |
Letter comments on EJC published paper: ‘No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study’
|
Zahl, Per Henrik
|
|
2018
|
97 |
C |
p. 49-50
|
artikel
|
| 8 |
Low-level postoperative carcinoembryonic antigen improves survival outcomes stratification in patients with stage II colon cancer treated with standard adjuvant treatments
|
Auclin, E.
|
|
2018
|
97 |
C |
p. 55-56
|
artikel
|
| 9 |
More is more? Pushing chemoradiotherapy of oesophageal squamous cell carcinoma forward
|
Lordick, Florian
|
|
2018
|
97 |
C |
p. 25-26
|
artikel
|
| 10 |
Refining the use of cabazitaxel in metastatic castrate-resistant prostate cancer
|
Culine, Stéphane
|
|
2018
|
97 |
C |
p. 30-32
|
artikel
|
| 11 |
Re: No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer Study
|
Lund, Eiliv
|
|
2018
|
97 |
C |
p. 51-52
|
artikel
|
| 12 |
Role of perioperative chemotherapy in soft-tissue sarcomas: It's time to end a never-ending story
|
Italiano, A.
|
|
2018
|
97 |
C |
p. 53-54
|
artikel
|
| 13 |
The International Cardioncology Society–ONE trial: Not all that glitters is for cardioncologists only
|
Minotti, Giorgio
|
|
2018
|
97 |
C |
p. 27-29
|
artikel
|
| 14 |
Weekly versus 3-weekly cabazitaxel for the treatment of castration-resistant prostate cancer: A randomised phase II trial (ConCab)
|
Yachnin, Jeffrey
|
|
2018
|
97 |
C |
p. 33-40
|
artikel
|
Tijdschrift beschrijving